Follow
Linda E. Klumpers
Linda E. Klumpers
Clinical Scientist
Verified email at chdr.nl
Title
Cited by
Cited by
Year
Brief treatment with the glucocorticoid receptor antagonist mifepristone normalises the corticosterone‐induced reduction of adult hippocampal neurogenesis
JL Mayer, L Klumpers, S Maslam, ER De Kloet, M Joels, PJ Lucassen
Journal of neuroendocrinology 18 (8), 629-631, 2006
2172006
Manipulating brain connectivity with δ9-tetrahydrocannabinol: a pharmacological resting state FMRI study
LE Klumpers, DM Cole, N Khalili-Mahani, RP Soeter, ET Te Beek, ...
Neuroimage 63 (3), 1701-1711, 2012
982012
A brief background on cannabis: From plant to medical indications
LE Klumpers, DL Thacker
Journal of AOAC International 102 (2), 412-420, 2019
892019
Novel Δ9‐tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects
LE Klumpers, TL Beumer, JGC van Hasselt, A Lipplaa, LB Karger, ...
British journal of clinical pharmacology 74 (1), 42-53, 2012
852012
Peripheral selectivity of the novel cannabinoid receptor antagonist TM 38837 in healthy subjects
LE Klumpers, M Fridberg, ML de Kam, PB Little, NO Jensen, HD Kleinloog, ...
British Journal of Clinical Pharmacology 76 (6), 846-857, 2013
752013
Population pharmacokinetic model of THC integrates oral, intravenous, and pulmonary dosing and characterizes short-and long-term pharmacokinetics
JAAC Heuberger, Z Guan, OO Oyetayo, L Klumpers, PD Morrison, ...
Clinical pharmacokinetics 54, 209-219, 2015
692015
Surinabant, a selective cannabinoid receptor type 1 antagonist, inhibits Δ9‐tetrahydrocannabinol‐induced central nervous system and heart rate effects in humans
LE Klumpers, C Roy, G Ferron, S Turpault, F Poitiers, JL Pinquier, ...
British Journal of Clinical Pharmacology 76 (1), 65-77, 2013
302013
Subjective Effects of Ethanol, Morphine, Δ9-Tetrahydrocannabinol, and Ketamine Following a Pharmacological Challenge Are Related to Functional Brain Connectivity
D Kleinloog, S Rombouts, R Zoethout, L Klumpers, M Niesters, ...
Brain connectivity 5 (10), 641-648, 2015
142015
Review of delta‐8‐tetrahydrocannabinol (Δ8‐THC): Comparative pharmacology with Δ9‐THC
M Tagen, LE Klumpers
British journal of pharmacology 179 (15), 3915-3933, 2022
112022
Surinabant, a selective CB (1) antagonist, inhibits THC-induced central nervous system and heart rate effects in humans
LE Klumpers, C Roy, G Ferron, S Turpault, F Poitiers, JL Pinquier, ...
Br J Clin Pharmacol 76, 65-77, 2013
52013
Pharmacokinetic/pharmaco–dynamic modelling and simulation of the effects of different cannabinoid receptor type 1 antagonists on Δ9‐tetrahydrocannabinol …
Z Guan, LE Klumpers, OO Oyetayo, J Heuberger, JMA van Gerven, ...
British Journal of Clinical Pharmacology 81 (4), 713-723, 2016
32016
Novel approaches in clinical development of cannabinoid drugs
LE Klumpers
Leiden University, 2014
12014
Pharmacologic resting state-FMRI: effects of cannabis on functional brain connectivity at rest
RP Soeter, LE Klumpers, N Khalili-Mahani, MA van Buchem, ...
Annual Meeting of the Organization for Human Brain Mapping, Barcelona, Spain, 2010
12010
Review of delta-8-tetrahydrocannabinol (Delta (8)-THC): Comparative pharmacology with Delta (9)-THC (vol 179, pg 3915, 2022)
M Tagen, LE Klumpers
BRITISH JOURNAL OF PHARMACOLOGY 180 (1), 130-130, 2023
2023
The Therapeutic Potential of Cannabis and the Endocannabinoid System
LE Klumpers, A Hazekamp
Principles and Practice of Botanicals as an Integrative Therapy, 393-417, 2019
2019
Sex differences in clinical pharmacology and gender differences in society: How to give an emerging industry a head start
L Klumpers
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 255, 2018
2018
Shaping the bright future of the cannabis industry: Because we can
L Klumpers, D Thacker, K Franson
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 255, 2018
2018
Does 1+ 1= 3? What science really knows about cannabinoid and terpene effects in humans
L Klumpers, K Franson
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 255, 2018
2018
Namisol: een nieuwe formulering van delta⁹-tetrahydrocannabinol met gunstige farmacokinetiek en veelbelovende farmacodynamische effecten
LE Klumpers, TL Beumer, JGC van Hasselt, A Lipplaa, LB Karger, ...
PW Wetenschappelijk Platform 9 (6), 122-31, 2015
2015
TETRAHYDROCANABINOL TABLET NAMISOL (R): FIRST IN HUMAN PK, PD AND TOLERABILITY
LE Klumpers, TL Beumer, LB Karger, A Lipplaa, ML de Kam, ...
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 72 (5), 854-854, 2011
2011
The system can't perform the operation now. Try again later.
Articles 1–20